LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Amathus Therapeutics

Amathus Therapeutics is developing small-molecule therapeutics for enhanced mitochondrial function which would enable treatment of a number of rare lysosomal-storage disorders as well as neurodegenerative diseases, such as Parkinson’s.

Amathus Therapeutics logo
Website - Coming Soon
  • Yiannis Ioannou, PhD Founder & Chair, Scientific Advisory Board
  • Ed Holson, PhD Chief Scientific Officer
  • Ross A. Fredenburg, PhD Director of In Vitro Pharmacology